Breaking News, Promotions & Moves

Oncodesign Services Taps Dr. Aidan Synnott as CEO

Synnott has extensive experience in global CRO operations and management and brings more than 20 years of experience in biomedical research.

Author Image

By: Charlie Sternberg

Associate Editor

Oncodesign Services has appointed Dr. Aidan Synnott as Chief Executive Officer, to help strengthen its position as a trusted partner in drug discovery. Synnott has extensive experience in global CRO operations and management and brings more than 20 years of experience in biomedical research. Most recently, he served as Corporate Vice President of Global Discovery Services at Charles River Laboratories. Throughout his career, he has led multidisciplinary teams across North America, Europe a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters